4//SEC Filing
Lettmann Jason 4
Accession 0001415889-25-008417
CIK 0001810182other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:41 PM ET
Size
4.9 KB
Accession
0001415889-25-008417
Insider Transaction Report
Form 4
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2025-03-14+42,000→ 212,270 total
Footnotes (1)
- [F1]The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026.
Documents
Issuer
ALX ONCOLOGY HOLDINGS INC
CIK 0001810182
Entity typeother
Related Parties
1- filerCIK 0001688269
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:41 PM ET
- Size
- 4.9 KB